
AV and UAS Denmark Establish Strategic Partnership to Advance Allied UAS Capabilities in Europe
ARLINGTON, Va.--(BUSINESS WIRE)--AeroVironment, Inc. ('AV') (NASDAQ: AVAV) today announced it has signed a Memorandum of Understanding (MOU) with Hans Christian Andersen Aiport in Odense, Denmark–home to the UAS Denmark Test Center–to explore joint utilization of the center's expansive airspace and advanced test facilities. The agreement aims to leverage UAS Denmark's strategic range and infrastructure to support AV's uncrewed aircraft system (UAS) demonstration operations, mission training, and customer integration activities across the region.
"Our partnership with UAS Denmark positions us to deliver enhanced capabilities, mission-critical training, and integrated UAS solutions to allied defense forces and government stakeholders across the region."
Share
The collaboration is expected to enable joint research and development (R&D) initiatives and accelerate the growth of the UAS Denmark Test Center as a regional epicenter for advanced UAS innovation, evaluation, and operational readiness.
"This MOU represents a significant milestone in expanding AV's operational footprint in Europe," said Shane Hastings, AV's vice president and general manager of Medium UAS. "Our partnership with UAS Denmark positions us to deliver enhanced capabilities, mission-critical training, and integrated UAS solutions to allied defense forces and government stakeholders across the region."
This agreement follows AV's February 2025 Framework Agreement with the Danish Ministry of Defence Acquisition and Logistics Organization (DALO), under which AV is delivering advanced UAS, operator and maintainer training, and lifecycle support to strengthen the Danish Armed Forces' intelligence, surveillance, and reconnaissance (ISR) capabilities. The MOU with UAS Denmark builds on this momentum and reinforces AV's commitment to delivering tactical advantage through scalable, reliable, and combat-proven UAS platforms.
By formalizing this collaboration, AV continues to expand its international partnerships and operational support capabilities—ensuring allied forces have access to the tools and training required to maintain readiness in dynamic environments.
ABOUT AEROVIRONMENT, INC.
AeroVironment ('AV') (NASDAQ: AVAV) is a defense technology leader delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities—built to meet the mission needs of today's warfighter and tomorrow's conflicts. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities with speed, scale, and operational relevance. For more information visit: www.avinc.com
ABOUT UAS DENMARK TEST CENTER
Located at Hans Christian Andersen Airport in Odense, the UAS Denmark Test Center is one of Europe's leading hubs for drone testing, development, and innovation. With access to a dedicated BVLOS airspace, state-of-the-art facilities, and a collaborative ecosystem of government, academia, and industry, the center supports the advancement of cutting-edge unmanned technologies. For more information, visit: https://uasdenmark.dk/
SAFE HARBOR STATEMENT
Certain statements in this press release may constitute "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are made on the basis of current expectations, forecasts and assumptions that involve risks and uncertainties, including, but not limited to, economic, competitive, governmental and technological factors outside of our control, that may cause our business, strategy or actual results to differ materially from those expressed or implied. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, our ability to perform under existing contracts and obtain additional contracts; changes in the regulatory environment; the activities of competitors; failure of the markets in which we operate to grow; failure to expand into new markets; failure to develop new products or integrate new technology with current products; and general economic and business conditions in the United States and elsewhere in the world. For a further list and description of such risks and uncertainties, see the reports we file with the Securities and Exchange Commission. We do not intend, and undertake no obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
2 hours ago
- Business Wire
Psycho Bunny Returns to Its Roots with New Store Opening in Queens, NY
MONTREAL--(BUSINESS WIRE)-- Psycho Bunny, the high-quality men's apparel brand known for its bold, expressive designs, is proud to announce the opening of its newest store at the Queens Center Mall in Queens, New York. This moment marks a meaningful homecoming for the brand, as 2025 celebrates Psycho Bunny's 20th anniversary and its founding in New York City. This milestone opening is more than just another retail expansion, it's a full-circle moment that reconnects the brand with its birthplace. Since its founding in 2005, Psycho Bunny has grown into a global fashion powerhouse, with over 130 stores worldwide. Now, two decades later, the brand is planting deeper roots in the city where it all began. 'Opening a store in Queens during our 20th anniversary year is incredibly special,' said Kenny Minzberg, Chief Development Officer of Psycho Bunny. 'New York is part of our DNA, and this location allows us to celebrate where we've been while continuing to build where we're going. Queens is a dynamic borough that aligns with our brand's spirit of individuality.' Located at one of the city's most iconic shopping destinations, the new Psycho Bunny store at Queens Center Mall invites locals and visitors alike to explore its premium lifestyle offerings from the perfect polo to bold seasonal collections. Known for its vibrant color palettes, tailored fits, and rebellious energy, the brand continues to inspire self-expression through elevated menswear. As Psycho Bunny celebrates 20 years of redefining modern menswear, the Queens store is both a tribute to its roots and a bold step into its next chapter. ABOUT PSYCHO BUNNY: Headquartered in Montreal, Psycho Bunny is a global premium clothing brand recognized for its bold designs, uncompromising quality, and iconic bunny logo. Since its founding in 2005, the brand has redefined modern style by blending classic sophistication with a playful, irreverent edge. Originally known for its premium polo shirts, Psycho Bunny has expanded to offer a full range of apparel and accessories for men, women, and children. With nearly 150 stores worldwide and a commitment to excellence, the brand continues to grow, crafting elevated fashion from the world's finest materials. Psycho Bunny's relentless commitment to consummate quality, striking design, and a thoroughly audacious, adventurous lifestyle can be experienced in its retail locations. More than just fashion, it represents a state of mind, an attitude, an ethos, a mantra, a rallying cry, and a veritable religion—anchored by one thoroughly iconic Bunny logo.
Yahoo
2 hours ago
- Yahoo
Penguin Solutions Announces Third Quarter Fiscal 2025 Financial Conference Call
MILPITAS, Calif., June 18, 2025--(BUSINESS WIRE)--Penguin Solutions, Inc. ("Penguin Solutions") (Nasdaq: PENG), a leading designer and developer of high-performance, high-availability enterprise solutions, today announced that the company will host its quarterly financial webcast and conference call for its third quarter fiscal year 2025 earnings after market close on Tuesday, July 8, 2025, beginning at 1:30 p.m. Pacific Time (PT) / 4:30 p.m. Eastern Time (ET). Financial results will be issued in a press release prior to the conference call. Webcast Information: To access the live webcast: PENG Q3 FY25 Earnings Call Webcast. Conference Call Information: Participants may also listen to the conference call by dialing:+1-833-470-1428 (domestic) or +1-404-975-4839 (international), using the access code 305335. Replay Information: An archived version of the webcast will be available on the Penguin Solutions investor relations website for one year after the webcast date at In addition, an audio replay of the call will be accessible for one week after the conference call by dialing +1-866-813-9403 (domestic) or +44 204 525 0658 (international), using the access code 979651. About Penguin Solutions The most exciting technological advancements are also the most challenging for companies to adopt. At Penguin Solutions, we support our customers in achieving their ambitions across our Advanced Computing, Integrated Memory, and Optimized LED business segments. With our expert skills, experience, and partnerships, we turn our customers' most complex challenges into compelling opportunities. For more information, visit View source version on Contacts Investor Contact Suzanne SchmidtInvestor Relations(510) 360-8596ir@ PR Contact Maureen O'LearyPenguin Solutions Corporate Communications(602) 330-6846pr@


Business Wire
2 hours ago
- Business Wire
Securities Fraud Investigation Into Rocket Pharmaceuticals, Inc. (RCKT) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES--(BUSINESS WIRE)-- The Law Offices of Frank R. Cruz announces an investigation of Rocket Pharmaceuticals, Inc. ('Rocket' or the 'Company') (NASDAQ: RCKT) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ROCKET PHARMACEUTICALS, INC. (RCKT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On May 27, 2025, Rocket disclosed that the FDA had placed a clinical hold on the Phase 2 pivotal trial of its Danon disease treatment, RP-A501, after at least one patient died following a substantive amendment to the protocol that the Company had not disclosed until after the Serious Adverse Event ('SAE') occurred. On this news, Rocket's stock price fell $3.94, or 62.8%, to close at $2.33 per share on May 27, 2025, thereby injuring investors. Contact Us To Participate or Learn More: If you purchased Rocket securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: The Law Offices of Frank R. Cruz 2121 Avenue of the Stars, Suite 800 Century City, California 90067 Call us at: 310-914-5007 Email us at: info@ Visit our website at: Follow us for updates on Twitter at If you inquire by email, please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.